New Delhi: Union Health Minister Harsh Vardhan said that late-stage clinical trials of intranasal COVID-19 vaccines are expected to be pursued by Serum Institute of India and Bharat Biotech once they receive regulatory approval.
The minister also said the late-stage trial usually involves 30,000 to 40,000 participants. Currently, the vaccines currently in Phase 3 trials are administered by injection, as per the World Health Organization (WHO).
According to India’s Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) on Saturday, they have received renewed approval for performing late-stage clinical trials in India of the Russian COVID-19 vaccine.
In the past 24 hours, India’s coronavirus infections surged by another 61,871, data released on Sunday showed.
Mumbai: The much-delayed schedule for the 2025 Champions Trophy has been finalised. As per the…
Raipur: Did actor Sunny Leone enroll for a Chhattisgarh government’s beneficiary scheme for economically weaker…
Berhampur: Continuing to target places of worship in different parts of Odisha, burglars struck at…
New York: US President-elect Donald Trump has nominated an Indian American entrepreneur and former aide…
New Delhi: BJP MPs Pratap Sarangi and Mukesh Rajput, who suffered head injuries in the…
Pune: Three people, including two toddlers, died on Monday when a dumper truck run over…
This website uses cookies.